Application of antibody-mediated extraction for the stereoselective determination of the active metabolite of loxoprofen in human and rat plasma
Author:
Publisher
Wiley
Subject
Organic Chemistry,Spectroscopy,Drug Discovery,Pharmacology,Catalysis,Analytical Chemistry
Reference23 articles.
1. Regulatory aspects of the development of chiral drugs in Japan: A status report
2. Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development
3. Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Simultaneous stereoisomeric separation of loxoprofen sodium and its alcohol metabolites. Application to a stereoselective pharmacokinetic study;Arabian Journal of Chemistry;2023-08
2. Preparative enantioseparation of loxoprofen precursor by recycling countercurrent chromatography with hydroxypropyl-β-cyclodextrin as a chiral selector;Journal of Separation Science;2018-05-22
3. Influence of nonsteroidal anti-inflammatory drugs on aspirin’s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction;Journal of Pharmaceutical Health Care and Sciences;2017-03-09
4. Pharmacokinetics/pharmacodynamics Analysis of Antiplatelet Effects of Non-steroidal Anti-inflammatory Drugs;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2015
5. Comparative inhibition of tetrameric carbonyl reductase activity in pig heart cytosol by alkyl 4-pyridyl ketones;Journal of Enzyme Inhibition and Medicinal Chemistry;2013-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3